Ayala Pharmaceuticals (AYLA) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free AYLA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Ayala Pharmaceuticals Short Interest DataCurrent Short Volume48,200 sharesPrevious Short Volume74,000 sharesChange Vs. Previous Month-34.86%Dollar Volume Sold Short$19,284.82Short Interest Ratio / Days to Cover0.6Last Record DateDecember 30, 2022Outstanding Shares14,821,000 sharesFloat Size10,740,000 sharesShort Percent of Float0.45%Today's Trading Volume137,700 sharesAverage Trading Volume76,300 sharesToday's Volume Vs. Average180% Short Selling Ayala Pharmaceuticals ? Sign up to receive the latest short interest report for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAYLA Short Interest Over TimeAYLA Days to Cover Over TimeAYLA Percentage of Float Shorted Over Time Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Ayala Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/30/202248,200 shares $19,284.82 -34.9%0.5%0.6 $0.40 12/15/202274,000 shares $40,700.00 -50.3%0.7%0.5 $0.55 11/30/2022148,800 shares $81,840.00 -21.1%1.4%0.8 $0.55 11/15/2022188,500 shares $109,518.50 -46.9%1.8%0.6 $0.58 10/31/2022354,900 shares $269,724.00 +15.7%4.8%1.1 $0.76 10/15/2022306,700 shares $282,164.00 -56.5%4.1%0.1 $0.92 Get the Latest News and Ratings for AYLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/30/2022705,400 shares $705,400.00 +145.9%9.6%0.3 $1.00 9/15/2022286,900 shares $393,053.00 +16.2%3.9%0.1 $1.37 8/31/2022246,900 shares $404,916.00 +1,524.3%3.5%0.1 $1.64 8/15/202215,200 shares $19,000.00 -98.0%0.2%0 $1.25 7/31/2022775,500 shares $1.33 million +2,459.4%11.6%0.3 $1.71 7/15/202230,300 shares $36,057.00 -6.5%0.5%0.3 $1.19 6/30/202232,400 shares $35,316.00 -27.8%0.5%0.6 $1.09 6/15/202244,900 shares $62,860.00 -52.5%0.7%0.8 $1.40 5/31/202294,500 shares $167,265.00 +1,650.0%1.4%1.7 $1.77 5/15/20225,400 shares $10,800.00 -15.6%0.1%0.2 $2.00 4/30/20226,400 shares $16,128.00 -63.6%0.1%0.3 $2.52 4/15/202217,600 shares $54,032.00 +33.3%0.4%0.7 $3.07 3/31/202213,200 shares $52,536.00 +428.0%0.3%0.5 $3.98 3/15/20222,500 shares $8,975.00 -95.2%0.1%0.1 $3.59 2/28/202251,500 shares $204,455.00 -0.6%1.1%1.7 $3.97 2/15/202251,800 shares $266,770.00 -14.5%1.1%1.7 $5.15 1/31/202260,600 shares $344,208.00 -4.9%1.3%1.8 $5.68 1/15/202263,700 shares $422,331.00 +14.2%1.4%2 $6.63 12/31/202155,800 shares $474,858.00 -30.4%1.4%2 $8.51 12/15/202180,200 shares $722,602.00 -36.1%2.0%3.4 $9.01 11/30/2021125,500 shares $1.19 million +2.5%3.8%4 $9.50 11/15/2021122,500 shares $1.38 million -2.2%3.7%4.2 $11.25 10/29/2021125,200 shares $1.37 million -0.5%3.8%4.4 $10.98 10/15/2021125,800 shares $1.26 million +1.2%3.8%3.8 $10.00 9/30/2021124,300 shares $1.41 million -3.3%3.7%3.2 $11.34 9/15/2021128,600 shares $1.81 million +1.4%3.9%3.3 $14.09 8/31/2021126,800 shares $1.61 million -10.1%3.8%4.3 $12.67 8/13/2021141,000 shares $1.72 million +3.9%4.2%4.9 $12.21 7/30/2021135,700 shares $1.70 million -11.3%4.1%5.1 $12.50 7/15/2021153,000 shares $1.81 million +8.4%4.6%7.3 $11.86 6/30/2021141,100 shares $1.44 million -3.7%4.2%7.7 $10.19 6/15/2021146,500 shares $1.52 million +1.7%4.4%12.2 $10.35 5/28/2021144,000 shares $1.37 million +0.2%4.3%12.2 $9.54 5/14/2021143,700 shares $1.41 million -1.2%4.3%9.6 $9.80Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. AYLA Short Interest - Frequently Asked Questions What is Ayala Pharmaceuticals' current short interest? Short interest is the volume of Ayala Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 30th, traders have sold 48,200 shares of AYLA short. 0.45% of Ayala Pharmaceuticals' shares are currently sold short. Learn More on Ayala Pharmaceuticals' current short interest. What is a good short interest ratio for Ayala Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AYLA shares currently have a short interest ratio of 1.0. Learn More on Ayala Pharmaceuticals's short interest ratio. What is a good short interest percentage for Ayala Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Ayala Pharmaceuticals' floating shares are currently sold short. Is Ayala Pharmaceuticals' short interest increasing or decreasing? Ayala Pharmaceuticals saw a drop in short interest in December. As of December 30th, there was short interest totaling 48,200 shares, a drop of 34.9% from the previous total of 74,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ayala Pharmaceuticals' float size? Ayala Pharmaceuticals currently has issued a total of 14,821,000 shares. Some of Ayala Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ayala Pharmaceuticals currently has a public float of 10,740,000 shares. How does Ayala Pharmaceuticals' short interest compare to its competitors? 0.45% of Ayala Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ayala Pharmaceuticals: Titan Pharmaceuticals, Inc. (1.72%), Creative Medical Technology Holdings, Inc. (1.76%), Genetic Technologies Limited (0.41%), Fresh Tracks Therapeutics, Inc. (0.17%), Palisade Bio, Inc. (4.12%), Organovo Holdings, Inc. (1.49%), BioCardia, Inc. (1.01%), Finch Therapeutics Group, Inc. (1.96%), TRACON Pharmaceuticals, Inc. (1.16%), Avalon GloboCare Corp. (2.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.31 billion), T. Rowe Price Group, Inc. ($2.13 billion), TC Energy Co. ($2.13 billion), Paramount Global ($1.50 billion), Coinbase Global, Inc. ($1.48 billion), Etsy, Inc. ($1.48 billion), PG&E Co. ($1.47 billion), Old Dominion Freight Line, Inc. ($1.46 billion), United Rentals, Inc. ($1.35 billion), and Voya Financial, Inc. ($1.32 billion). View all of the most shorted stocks. What does it mean to sell short Ayala Pharmaceuticals stock? Short selling AYLA is an investing strategy that aims to generate trading profit from Ayala Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ayala Pharmaceuticals? A short squeeze for Ayala Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AYLA, which in turn drives the price of the stock up even further. How often is Ayala Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AYLA, twice per month. The most recent reporting period available is December, 30 2022. More Short Interest Resources from MarketBeat Related Companies: Titan Pharmaceuticals Short Interest Creative Medical Technology Short Interest Genetic Technologies Short Interest Fresh Tracks Therapeutics Short Interest Palisade Bio Short Interest Organovo Short Interest BioCardia Short Interest Finch Therapeutics Group Short Interest TRACON Pharmaceuticals Short Interest Avalon GloboCare Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AYLA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings